Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial
Titel:
Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial
Auteur:
Vinik, Aaron I. Bril, Vera Kempler, Peter Litchy, William J. Tesfaye, Solomon Price, Karen L. Bastyr III, Edward J.